New York Post - July 20, 2021
Nir Barzilai, M.D., talks about his plans for a clinical trial to study metformin, a diabetes drug, to target age-related diseases. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Medscape - July 19, 2021
Matthew Akiyama, M.D., describes his National Institutes of Health award to use new sequencing technology to understand HIV and hepatitis C transmission, which may lead to new prevention and treatment strategies for the diseases. Dr. Akiyama is associate professor of medicine at Einstein and an internist at Montefiore.
Dr. Akiyama's ProfileMore coverage on Dr. Akiyama
Science News - July 14, 2021
Suzette Olu Bousola Oyeku, M.D., M.P.H., comments on the significant increase in the number of children worldwide who have missed vaccinations for preventable diseases like measles, diphtheria, tetanus, and pertussis, and warns that clusters of outbreaks could occur as a result. Dr. Oyeku is professor of pediatrics at Einstein and chief of the division of academic general pediatrics at the Children’s Hospital at Montefiore (CHAM).
Dr. Oyeku's Profile
Medscape - July 9, 2021
Priya Nori, M.D., discusses the disagreement between Pfizer and the Centers for Disease Control about COVID-19 booster shots, and says a more important issue is vaccine equity and the need to provide initial shots for healthcare workers in low- and middle-income countries. Dr. Nori is associate professor of medicine and of orthopaedic surgery at Einstein and Montefiore.
Dr. Nori's ProfileMore coverage on Dr. Nori
National Institute on Aging - July 8, 2021
Carol Derby, Ph.D., led research in the National Institutes of Health-supported Study of Women's Health Across the Nation (SWAN) that found heart disease risk factors, such as high blood pressure, diabetes, and belly fat, were associated with declines in cognitive processing speed during midlife. Dr. Derby is research professor in the Saul R. Korey Department of Neurology and in the department of epidemiology & population health and is the Louis and Gertrude Feil Faculty Scholar in Neurology at Einstein. She is principal investigator of the Einstein site of the SWAN study underway at seven clinical centers across the United States.
Dr. Derby's Profile
The Scientist - July 1, 2021
Libusha Kelly, Ph.D., describes SARS-CoV-2 sequencing efforts at Einstein and Montefiore and calls for a robust national genomic sequencing program to help scientists detect, understand, and stay ahead of new and developing viral variants. Dr. Kelly is associate professor of systems & computational biology and of microbiology & immunology.
Dr. Kelly's ProfileMore coverage on Dr. Kelly
The Washington Post - June 17, 2021
Richard Lipton, M.D., says he supports the FDA's approval of a controversial new drug to treat Alzheimer's, and notes that he would have given the drug to his late mother, who suffered from the disease. Dr.Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein and Montefiore.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
Daily Mail - June 10, 2021
Balazs Halmos, M.D., and Amit Verma, M.B.B.S., comment on their study that finds patients with cancer developed antibodies to COVID-19 after vaccination. Dr. Halmos is director of the Multidisciplinary Thoracic Oncology Program at Montefiore and professor of medicine at Einstein; Dr. Verma is associate director of translational science at the Albert Einstein Cancer Center and director of the division of hemato-oncology at Montefiore.
Dr. Halmos' Profile
The New York Times - June 4, 2021
An Einstein alumna and current Montefiore resident shares her experiences graduating during the height of the pandemic in spring 2020 and starting her career caring for critically ill patients with COVID-19.
The Boston Globe - June 4, 2021
Tia Powell, M.D., explains that a diagnosis of Alzheimer's disease is often accompanied by shame and fear, which can increase the burden on caretakers. Dr. Powell is the Dr. Shoshana Trachtenberg Frackman Faculty Scholar in Biomedical Ethics and director of the Montefiore Einstein Center for Bioethics.
Dr. Powell's ProfileMore coverage on Dr. Powell
Fast Company - June 4, 2021
Maureen Brogan, M.D., discusses rhabdomyolysis, a painful and dangerous syndrome involving muscle overexertion that often results from starting or restarting a rigorous exercise regime. Dr. Brogan is associate professor of medicine at Einstein and a nephrologist at Montefiore.
Dr. Brogan's Profile
Allure - June 1, 2021
Dawn Buse, Ph.D., says people with migraine can still experience fatigue and difficulty concentrating in the postdrome phase of migraine, when most of the other severe headache symptoms have resolved. Dr. Buse is clinical professor in the Saul R. Korey Department of Neurology.
Dr. Buse's ProfileMore coverage on Dr. Buse
American Heart Association News - May 21, 2021
Jonathan Oxman, M.D., a 2021 graduate of Einstein, describes the research he conducted at the College of Medicine that found a link between perceived discrimination by Hispanic adults and changes in their cardiac structure and function that could lead to cardiovascular disease.
MIT Technology Review - May 13, 2021
Kartik Chandran, Ph.D., explains that despite the existence of variants to COVID-19, the virus has not fundamentally changed, and stresses the importance of using the current effective vaccines to control the pandemic. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.
Dr. Chandran's ProfileMore coverage on Dr. Chandran
Medscape - May 11, 2021
Iman Hassan, M.D., M.S., comments on anti-racist training in medical education using a structural competency framework, which equips physicians with the tools to identify, discuss, and work with patients to address the social, political, and economic structures that affect their health. Dr. Hassan is assistant professor of medicine at Einstein and an internist at Montefiore.
Dr. Hassan's Profile
Nature - September 2, 2020
In a commentary for Nature, Gary Schwartz, Ph.D., writes about the discovery of a pathway in the preoptic area of the brain in mice by which a light-sensitive protein regulates heat production. The findings may lead to ways of altering metabolism by manipulating environmental light. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.
Dr. Schwartz's ProfileMore coverage on Dr. Schwartz
Leukaemia Foundation MDS News - April 30, 2020
Ulrich Steidl, M.D., Ph.D., discusses his research on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and his hope that basic science and translational studies will lead to successful drug treatments for patients. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research and professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is chair of ophthalmology & vision services at Einstein and Montefiore Medical Center.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion